BeOne Medicines Ltd. (ONC) ownership: Amgen Inc. 23% · institutions 3% · index and ETF funds 0% (13F 2026-06-30). Insider activity, 90 days: 111 sales, 0 open-market buys. SEC EDGAR first-party data.
| Holder | Shares | Market Value | % Outstanding | Reported |
|---|---|---|---|---|
| Baker BROS. Advisors LP | 8801567.00 | $2.51B | 0.6% | 2026-06-30 |
| Capital Group | 7058029.00 | $2.01B | 0.5% | 2026-06-30 |
| Primecap Management Co | 5007931.00 | $1.43B | 0.3% | 2026-06-30 |
| FMR (Fidelity) | 2478527.00 | $706.31M | 0.2% | 2026-06-30 |
| Citadel | 1425517.00 | $406.23M | 0.1% | 2026-06-30 |
| Hhlr Advisors, Ltd. | 1034306.00 | $307.16M | 0.1% | 2026-06-30 |
| Temasek | 845729.00 | $241.01M | 0.1% | 2026-06-30 |
| Price T Rowe Associates Inc | 758752.00 | $216.22M | 0.1% | 2026-06-30 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-09-08 | |
| Sell | null | 2026-09-08 | |
| Sell | null | 2026-09-08 | |
| Sell | null | 2026-09-08 | |
| Sell | null | 2026-09-08 | |
| Sell | null | 2026-09-08 | |
| Sell | null | 2026-09-08 | |
| Sell | null | 2026-09-08 |
Back to ONC overview · ONC earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.